{"id":8408,"date":"2024-04-18T17:38:26","date_gmt":"2024-04-18T09:38:26","guid":{"rendered":"https:\/\/www.1ai.net\/?p=8408"},"modified":"2024-04-18T17:38:26","modified_gmt":"2024-04-18T09:38:26","slug":"%e7%a0%94%e7%a9%b6%e5%8f%91%e7%8e%b0%ef%bc%8cchatgpt%e5%9c%a8%e8%80%81%e5%b9%b4%e8%8d%af%e7%89%a9%e7%ae%a1%e7%90%86%e4%b8%ad%e5%b1%95%e7%8e%b0%e6%bd%9c%e5%8a%9b","status":"publish","type":"post","link":"https:\/\/www.1ai.net\/en\/8408.html","title":{"rendered":"Study finds ChatGPT shows potential in elderly medication management"},"content":{"rendered":"

In a new study, researchers from the Mass General Brigham MESH Incubator found that AI-generated chatbots ChatGPT<\/a> The study, published in the Journal of Medical Systems, shows the potential of AI models in managing polypharmacy and drug deprescribing.Medical<\/a>In managementThe first<\/span>Application cases.<\/p>\n

To evaluate the usefulness of ChatGPT, the researchers presented it with different clinical scenarios and asked it a series of decision-making questions. Each scenario included the same elderly patient who was taking multiple medications but had varying histories of cardiovascular disease and levels of impairment in activities of daily living.<\/p>\n

\"202310270933190076_7\"<\/p>\n

Source: The image is generated by AI, and the image is authorized by Midjourney<\/p>\n

When asked whether to reduce prescribed medications, ChatGPT consistently recommended reducing medications in patients without a history of cardiovascular disease. However, when known cardiovascular disease was introduced, ChatGPT was more cautious and more likely to keep the patient's medication prescription unchanged. The researchers observed that regardless of the severity of impairment in activities of daily living, there did not seem to be an impact on decision outcomes.<\/p>\n

The research team also noticed that ChatGPT tended to discount pain and favored reducing pain medications over other drug types, such as statins or blood pressure medications. In addition, ChatGPT\u2019s responses varied when presented with the same scenario in a new chat session, which may reflect inconsistencies in the clinical deprescribing trends used to train the model.<\/p>\n

Older adults with more than 40% met the criteria for polypharmacy. In recent years, older adults enrolled in Medicare have received care from more specialist teams, resulting in the need for primary care providers to monitorMedication management<\/a>According to the researchers, effective AI tools could help alleviate this situation.<\/p>\n

ResearchSenior<\/span>"Our study provides new insights into ChatGPT as a clinical support tool for medication management," said corresponding author Marc Succi, PhD, a professor of medicine at Harvard Medical School.The first<\/span>Although the accuracy of such models should be improved with caution, AI-Assisted<\/a>\u201cThe management of polypharmacy can help reduce the burden on primary care physicians. Further research into specifically trained AI tools could significantly improve the care of older patients.\u201d<\/p>","protected":false},"excerpt":{"rendered":"

In a new study, researchers from Mass General Brigham MESH Incubator have found that the AI generative chatbot ChatGPT shows potential as a way to manage polypharmacy and drug de-prescribing. The findings, published in the Journal of Medical Systems, demonstrate the first use case of an AI model in healthcare management. To assess ChatGPT's utility, the researchers presented it with different clinical scenarios and asked a series of decision-making questions. Each scenario included the same elderly patient taking multiple medications, but with variations in cardiovascular disease history and impaired activities of daily living. Image credit note:Image generated by AI, image licensed from service provider Midjour<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[146],"tags":[1831,177,211,2289],"collection":[],"class_list":["post-8408","post","type-post","status-publish","format-standard","hentry","category-news","tag-ai","tag-chatgpt","tag-211","tag-2289"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/posts\/8408","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/comments?post=8408"}],"version-history":[{"count":0,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/posts\/8408\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/media?parent=8408"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/categories?post=8408"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/tags?post=8408"},{"taxonomy":"collection","embeddable":true,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/collection?post=8408"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}